Neuroscience
Functional Magnetic Resonance Imaging
100%
Visual Cortex
56%
Magnetic Resonance Imaging
51%
5-HT2A Receptor
45%
Electroconvulsive Therapy
43%
positron emission tomographic scan
41%
Magnetic Resonance Imaging
38%
Nerve Potential
36%
Erythropoietin
36%
Positron Emission Tomography
35%
Metabolic Pathway
35%
Hippocampus
34%
Multiple Sclerosis
34%
Mood Disorder
33%
Serotonin
31%
Occipital Lobe
29%
Receptor Binding
27%
Serotonergic
26%
Cognitive Disorder
25%
Longitudinal Study
25%
Citalopram
24%
Autoregulation
24%
Face
24%
Gray Matter
23%
Fusiform Gyrus
22%
Altanserin
22%
Amygdala
22%
Diffusion MRI
22%
Thalamus
21%
Glucocorticoid
21%
Transcranial Magnetic Stimulation
21%
Brain Areas
21%
N-Acetylaspartic Acid
20%
Temporal Lobe
18%
Placebo
18%
Visual Pathway
18%
Receptor
18%
Tryptophan
17%
Cerebellum
17%
Major Depressive Disorder
16%
Migraine
16%
Single-Photon Emission Computed Tomography
15%
Orbitofrontal Cortex
15%
Gray Matter Volume
15%
Bipolar Disorder
15%
Keyphrases
Functional Magnetic Resonance Imaging
67%
Regional Cerebral Blood Flow (rCBF)
47%
Electroconvulsive Therapy
43%
Cerebral Blood Flow
41%
Erythropoietin
36%
Neural Response
33%
Serotonin 2A Receptor (5-HT2AR)
30%
Cerebral Autoregulation
30%
5-HT2A Receptor
29%
Gray Matter Volume
26%
Magnetic Resonance Imaging Study
25%
Mood Disorders
25%
Visual Cortex
25%
Brain Regions
22%
Brain Volume Changes
21%
Regional Brain Volumes
21%
Cerebral Glucose Metabolism
21%
Sham Control
21%
Severe Traumatic Brain Injury (sTBI)
21%
Hippocampal Volume
20%
Diffusion-weighted Imaging
20%
Glucocorticoid Therapy
19%
Cardiac Surgery
18%
Congenitally Blind
18%
Healthy Controls
18%
Positron Emission Tomography
17%
Previously Treated
17%
Randomized Trial
17%
Lower Limit
17%
Congenital Blindness
17%
Whole Brain
16%
Radiotherapy
16%
Cardiopulmonary Bypass
16%
Receptor Binding
16%
Hippocampus
16%
Postoperative Cognitive Dysfunction
15%
Neural Correlates
15%
Orbitofrontal Cortex
15%
Bipolar Disorder
15%
Amygdala
15%